Histopathology and molecular genetics of renal tumors: Toward unification of a classification system

Journal of Urology

Volumn 162, Issue 4, 1999, Pages 1246-1258

  Zambrano, N R ^a   Lubensky, I A ^a   Merino, M J ^a   Linehan, W M ^a   Walther, M M ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Carcinoma, renal cell; Classification; Genes; Histology; Pathology

Indexed keywords

CLEAR CELL CARCINOMA; CYSTADENOMA; HISTOPATHOLOGY; HUMAN; KIDNEY CARCINOMA; MOLECULAR GENETICS; ONCOCYTOMA; PAPILLARY CARCINOMA; PRIORITY JOURNAL; REVIEW; VON HIPPEL LINDAU DISEASE;

EID: 0032869860     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)68259-6     Document Type: Review

References (199)

1. Storkel S. Eble J.N. Adlakha K. Amin M. Blute M.L. Bostwick D.G. Darson M. Delahunt B. Iczkowski K. Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC) Cancer 80 1997 987
2. Beaty M.W. Zhuang Z. Park W.S. Emmert-Buck M.R. Linehan W.M. Lubensky I.A. Abati A. Fine-needle aspiration of metastatic clear cell carcinoma of the kidney: employment of microdissection and the polymerase chain reaction as a potential diagnostic tool Cancer 81 1997 180
3. Linehan W.M. Lerman M.I. Zbar B. Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer J.A.M.A. 273 1995 564
4. Glenn G.M. Choyke P.L. Zbar B. Linehan W.M. Von Hippel-Lindau disease: clinical review and molecular genetics E. Anderson Problems in Urologic Surgery: Benign and Malignant Tumors of the Kidney 1990 J.B. Lippincott Philadelphia 312 330
5. Poston C.D. Jaffe G.S. Lubensky I.A. Solomon D. Zbar B. Linehan W.M. Walther M.M. Characterization of the renal pathology of a familial form of renal cell carcinoma associated with von Hippel-Lindau disease: clinical and molecular genetic implications J. Urol. 153 1995 22
6. Cohen A.J. Li F.P. Berg S. Marchetto D.J. Tsai S. Jacobs S.C. Brown R.S. Hereditary renal-cell carcinoma associated with a chromosomal translocation New Engl. J. Med. 301 1979 592
7. Kovacs G. Brusa P. De Riese W. Tissue-specific expression of a constitutional 3;6 translocation: development of multiple bilateral renal-cell carcinomas Int. J. Cancer 43 1989 422
8. Wang N. Perkins K.L. Involvement of band 3p14 in t(3;8) hereditary renal carcinoma Cancer Genet. Cytogenet. 11 1984 479
9. Li F.P. Decker H.J. Zbar B. Stanton V.P. Jr. Kovacs G. Seizinger B.R. Aburatani H. Sandberg A.A. Berg S. Hosoe S. Clinical and genetic studies of renal cell carcinomas in a family with a constitutional chromosome 3;8 translocation. Genetics of familial renal carcinoma Ann Intern. Med. 118 1993 106
10. Koolen M.I. van der Meyden A.P. Bodmer D. Eleveld M. van der Looij E. Brunner H. Smits A. van den Berg E. Smeets D. Geurts van Kessel A. A familial case of renal cell carcinoma and a t(2;3) chromosome translocation Kidney Int. 53 1998 273
11. Zbar B. Tory K. Merino M. Schmidt L. Glenn G. Choyke P. Walther M.M. Lerman M. Linehan W.M. Hereditary papillary renal cell carcinoma J. Urol. 151 1994 561
12. Zbar B. Glenn G. Lubensky I. Choyke P. Walther M.M. Magnusson G. Bergerheim U.S. Pettersson S. Amin M. Hurley K. Hereditary papillary renal cell carcinoma: clinical studies in 10 families J. Urol. 153 part 2 1995 907
13. Weirich G. Glenn G. Junker K. Merino M. Störkel S. Lubensky I. Choyke P. Pack S. Amin M. Walther M.M. Linehan W.M. Zbar B. Familial renal oncocytoma: clinicopathological study of 5 families J. Urol. 160 1998 335
14. Fearon E.R. Vogelstein B. A genetic model for colorectal tumorigenesis Cell 61 1990 759
15. Kovacs G. Molecular differential pathology of renal cell tumours Histopathology 22 1993 1
16. Dijkhuizen T. Van Den Berg E. Van Den Berg A. Van De Veen A. Dam A. Faber H. Buys C.H. Störkel S. De Jong B. Genetics as a diagnostic tool in sarcomatoid renal-cell cancer Int. J. Cancer 72 1997 265
17. Knudson A.G. Jr. Strong L.C. Mutation and cancer: a model for Wilms' tumor of the kidney J. Natl. Cancer Inst. 48 1972 313
18. Knudson A.G. Jr. Mutation and cancer: statistical study of retinoblastoma Proc. Natl. Acad. Sci. 68 1971 820
19. Field J.K. Spandidos D.A. The role of ras and myc oncogenes in human solid tumours and their relevance in diagnosis and prognosis Anticancer Res. 10 1990 1
20. Bishop J.M. The molecular genetics of cancer Science 235 1987 305
21. Grawitz P. Die Enstehung von Nierentumoren aus Nebennierengewebe Arch. Klin. Chir. 30 1883 824
22. Thoenes W. Störkel S. Rumpelt H.J. Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics Path. Res. Pract. 181 1986 125
23. Kovacs G. Akhtar M. Beckwith B.J. Bugert P. Cooper C.S. Delahunt B. Eble J.N. Fleming S. Ljungberg B. Medeiros L.J. Moch H. Reuter V.E. Ritz E. Roos G. Schmidt D. Srigley J.R. Störkel S. van den Berg E. Zbar B. The Heidelberg classification of renal cell tumours [editorial] J. Path. 183 1997 131
24. Fleming S. The impact of genetics on the classification of renal carcinoma Histopathology 22 1993 89
25. Braunstein H. Adelman J.U. Histochemical study of the enzymatic activity of human neoplasms. II. Histogenesis of renal cell carcinoma Cancer 19 1966 935
26. Bennington J.L. Cancer of the kidney-etiology, epidemiology, and pathology Cancer 32 1973 1017
27. Wallace A.C. Nairn R.C. Renal tubular antigens in kidney tumors Cancer 29 1972 977
28. Fleming S. Lindop G.B. Gibson A.A. The distribution of epithelial membrane antigen in the kidney and its tumours Histopathology 9 1985 729
29. Goodman M.D. Goodman B.K. Lubin M.B. Braunstein G. Rotter J.I. Schreck R.R. Cytogenetic characterization of renal cell carcinoma in von Hippel-Lindau syndrome Cancer 65 1990 1150
30. Tory K. Brauch H. Linehan M. Barba D. Oldfield E. Filling-Katz M. Seizinger B. Nakamura Y. White R. Marshall F.F. Specific genetic change in tumors associated with von Hippel-Lindau disease J. Natl. Cancer Inst. 81 1989 1097
31. Latif F. Tory K. Gnarra J. Yao M. Duh F.M. Orcutt M.L. Stackhouse T. Kuzmin I. Modi W. Geil L. Identification of the von Hippel-Lindau disease tumor suppressor gene Science 260 1993 1317
32. Shi G. Cannizzaro L.A. Mapping of 29 YAC clones and identification of 3 YACs spanning the translocation t(3;8) (p14.2;q24.1) breakpoint at 8q24.1 in hereditary renal cell carcinoma Cytogenet. Cell Genet. 75 1996 180
33. Bodmer D. Eleveld M.J. Ligtenberg M.J. Weterman M.A. Janssen B.A. Smeets D.F. de Wit P.E. vanden Berg A. vanden Berg E. Koolen M.I. Geurts van Kessel A. An alternative route for multistep tumorigenesis in a novel case of hereditary renal cell carcinoma and a t(2;3)(q35;q21) chromosomal translocation Amer. J. Hum. Genet. 62 1998 1475
34. Gnarra J.R. Tory K. Weng Y. Schmidt L. Wei M.H. Li H. Latif F. Liu S. Chen F. Duh F.M. Mutations of the VHL tumour suppressor gene in renal carcinoma Natl. Genet. 7 1994 85
35. Schmidt L. Li F. Brown R.S. Berg S. Chen F. Wei M.H. Tory K. Lerman M.I. Zbar B. Mechanisms of tumorigenesis of renal carcinomas associated with the constitutional 3;8 translocation Cancer J. Sci. Amer. 1 1995 191
36. Anglard P. Tory K. Brauch H. Weiss G.H. Latif F. Mernio M.J. Lerman M.I. Zbar B. Linehan W.M. Molecular analysis of genetic changes in the origin and development of renal cell carcinoma Cancer Res. 51 1991 1071
37. Kovacs G. Emanuel A. Neumann H.P. Kung H.F. Cytogenetics of renal cell carcinomas associated with von Hippel-Lindau disease Genes Chromosomes Cancer 3 1991 256
38. Kenck C. Wilhelm M. Bugert P. Staehler G. Kovacs G. Mutation of the VHL gene is associated exclusively with the development of non-papillary renal cell carcinomas J. Path. 179 1996 157
39. Teyssier J.R. Ferre D. Chromosomal changes in renal cell carcinoma. No evidence for correlation with clinical stage Cancer Genet. Cytogenet. 45 1990 197
40. Thrash-Bingham C.A. Salazar H. Freed J.J. Greenberg R.E. Tartof K.D. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology Cancer Res. 55 1995 6189
41. Shuin T. Kondo K. Torigoe S. Kishida T. Kubota Y. Hosaka M. Nagashima Y. Kitamura H. Latif F. Zbar B. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas Cancer Res. 54 1994 2852
42. Foster K. Prowse A. van den Berg A. Fleming S. Hulsbeek M.M. Crossey P.A. Richards F.M. Cairns P. Affara N.A. Ferguson-Smith M.A. Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in nonfamilial clear cell renal carcinoma Hum. Mol. Genet. 3 1994 2169
43. Bird A.P. CpG-rich islands and the function of DNA methylation Nature 321 1986 209
44. Glavač D. Ravnik-Glavač M. Ovčak Z. Mašera A. Genetic changes in the origin and development of renal cell carcinoma (RCC) Pflugers Arch. 431 suppl. 1996 R193
45. Herman J.G. Latif F. Weng Y. Lerman M.I. Zbar B. Liu S. Samid D. Duan D.S. Gnawa J.R. Linehan W.M. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma Proc. Natl. Acad. Sci. 91 1994 9700
46. Suzuki H. Ueda T. Komiya A. Okano T. Isaka S. Shimazaki J. Ito H. Mutational state of von Hippel-Lindau and adenomatous polyposis coli genes in renal tumors Oncology 54 1997 252
47. Decker H.J. Neuhaus C. Jauch A. Speicher M. Ried T. Bujard M. Brauch H. Störkel S. Stöckle M. Seliger B. Huber C. Detection of a germline mutation and somatic homozygous loss of the von Hippel-Lindau tumor-suppressor gene in a family with a de novo mutation. A combined genetic study, including cytogenetics, PCR/SSCP, FISH, and CGH Hum. Genet. 97 1996 770
48. Foster K. Crossey P.A. Cairns P. Hetherington J.W. Richards F.M. Jones M.H. Bentley E. Affara N.A. Ferguson-Smith M.A. Maher E.R. Molecular genetic investigation of sporadic renal cell carcinoma: analysis of allele loss on chromosomes 3p, 5q, 11p, 17 and 22 Brit. J. Cancer 69 1994 230
49. Lubinski J. Hadaczek P. Podolski J. Toloczko A. Sikorski A. McCue P. Druck T. Huebner K. Common regions of deletion in chromosome regions 3p12 and 3p14.2 in primary clear cell renal carcinomas Cancer Res. 54 1994 3710
50. Ohta M. Inoue H. Cotticelli M.G. Kastury K. Baffa R. Palazzo J. Siprashvili Z. Mon M. McCue P. Druck T. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers Cell 84 1996 587
51. Bugert P. Wilhelm M. Kovacs G. FHIT gene and the FRA3B region are not involved in the genetics of renal cell carcinomas Genes Chromosomes Cancer 20 1997 9
52. Knebelmann B. Ananth S. Cohen H.T. Sukhatme V.P. Transforming growth factor alpha is a target for the von Hippel-Lindau tumor suppressor Cancer Res. 58 1998 226
53. Gomella L.G. Sargent E.R. Wade T.P. Anglard P. Linehan W.M. Kasid A. Expression of transforming growth factor alpha in normal human adult kidney and enhanced expression of transforming growth factors alpha and beta 1 in renal cell carcinoma Cancer Res. 49 1989 6972
54. Kinouchi T. Saiki S. Naoe T. Uenaka A. Kotake T. Shiku H. Nakayama E. Correlation of c-myc expression with nuclear pleomorphism in human renal cell carcinoma Cancer Res. 49 1989 3627
55. Weidner U. Peter S. Strohmeyer T. Hussnatter R. Ackermann R. Sies H. Inverse relationship of epidermal growth factor receptor and HER2/neu gene expression in human renal cell carcinoma Cancer Res. 50 1990 4504
56. Yao M. Shuin T. Misaki H. Kubota Y. Enhanced expression of c-myc and epidermal growth factor receptor (C-erbB-1) genes in primary human renal cancer Cancer Res. 48 1988 6753
57. Presti J.C. Jr. Moch H. Reuter V.E. Cordon-Cardo C. Waldman F.M. Renal cell carcinoma genetic analysis by comparative genomic hybridization and restriction fragment length polymorphism analysis J. Urol. 156 1996 281
58. Kenck C. Bugert P. Wilhelm M. Kovacs G. Duplication of an approximately 1.5 Mb DNA segment at chromosome 5q22 indicates the locus of a new tumour gene in nonpapillary renal cell carcinomas Oncogene 14 1997 1093
59. Kovacs G. Frisch S. Clonal chromosome abnormalities in tumor cells from patients with sporadic renal cell carcinomas Cancer Res. 49 1989 651
60. Kovacs G. Molecular cytogenetics of renal cell tumors Adv. Cancer Res. 62 1993 89
61. Gannon J.V. Greaves R. Iggo R. Lane D.P. Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form EMBO J. 9 1990 1595
62. Levine A.J. Momand J. Finlay C.A. The p53 tumour suppressor gene Nature 351 1991 453
63. Oda H. Nakatsuru Y. Ishikawa T. Mutations of the p53 gene and p53 protein overexpression are associated with sarcomatoid transformation in renal cell carcinomas Cancer Res. 55 1995 658
64. Hofmockel G. Wittmann A. Dammrich J. Bassukas I.D. Expression of p53 and bcl-2 in primary locally confined renal cell carcinomas: no evidence for prognostic significance Anticancer Res. 16 1996 3807
65. Reiter R.E. Anglard P. Liu S. Gnarra J.R. Linehan W.M. Chromosome 17p deletions and p53 mutations in renal cell carcinoma Cancer Res. 53 1993 3092
66. Tomita Y. Bilim V. Kawasaki T. Takahaski K. Okan I. Magnusson K.P. Wiman K.G. Frequent expression of Bcl-2 in renal-cell carcinomas carrying wild-type p53 Int. J. Cancer 66 1996 322
67. Akiyama T. Hamazaki S. Okada S. Absence of ras mutations and low incidence of p53 mutations in renal cell carcinomas induced by ferric nitrilotriacetate Jap. J. Cancer Res. 86 1995 1143
68. Uchida T. Wada C. Shitara T. Egawa S. Mashimo S. Koshiba K. Infrequent involvement of p53 mutations and loss of heterozygosity of 17p in the tumorigenesis of renal cell carcinoma J. Urol. 150 1993 1298
69. Suzuki Y. Tamura G. Satodate R. Fujioka T. Infrequent mutation of p53 gene in human renal cell carcinoma detected by polymerase chain reaction single-strand conformation polymorphism analysis Jap. J. Cancer Res. 83 1992 233
70. Presti J.C. Jr. Reuter V.E. Cordon-Cardo C. Mazumdar M. Fair W.R. Jhanwar S.C. Allelic deletions in renal tumors: histopathological correlations Cancer Res. 53 1993 5780
71. Wu S.Q. Hafez G.R. Xing W. Newton M. Chen X.R. Messing E. The correlation between the loss of chromosome 14q with histologic tumor grade, pathologic stage, and outcome of patients with nonpapillary renal cell carcinoma Cancer 77 1996 1154
72. Schullerus D. Herbers J. Chudek J. Kanamaru H. Kovacs G. Loss of heterozygosity at chromosomes 8p, 9p, and 14q is associated with stage and grade of non-papillary renal cell carcinomas J. Path. 183 1997 151
73. Bottaro D.P. Rubin J.S. Faletto D.L. Chan A.M. Kmiecik T.E. vande Woude G.F. Aaronson S.A. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product Science 251 1991 802
74. Pisters L.L. el-Naggar A.K. Luo W. Malpica A. Lin S-H. C-met proto-oncogene expression in benign and malignant human renal tissues J. Urol. 158 1997 724
75. Nakopoulou L. Vouriakou C. Papaliodi E. Lazaris A.C. Stefanaski K. Michalopoulos G. Immunodetection of c-met-oncogene's protein product in renal cell neoplasia Path. Res. Pract. 193 1997 299
76. Natali P.G. Prat M. Nicotra M.R. Bigotti A. Olivero M. Comoglio P.M. Di Renzo M.F. Overexpression of the met/HGF receptor in renal cell carcinomas Int. J. Cancer 69 1996 212
77. Sargent E.R. Gomella L.G. Belldegrun A. Linehan W.M. Kasid A. Epidermal growth factor receptor gene expression in normal human kidney and renal cell carcinoma J. Urol. 142 1989 1364
78. Koo A.S. Chiu R. Soong J. deKernion J.B. Belldegrun A. The expression of C-jun and junB mRNA in renal cell cancer and in vitro regulation by transforming growth factor beta 1 and tumor necrosis factor alpha 1 J. Urol. 148 1992 1314
79. Chandler D. el-Naggar A.K. Brisbay S. Redline R.W. McDonnell T.J. Apoptosis and expression of the bcl-2 proto-oncogene in the fetal and adult human kidney: evidence for the contribution of bcl-2 expression to renal carcinogenesis Hum. Path. 25 1994 789
80. Nanus D.M. Mentle I.R. Motzer R.J. Bander N.H. Albino A.P. Infrequent ras oncogene point mutations in renal cell carcinoma J. Urol. 143 1990 175
81. Rochlitz C.F. Peter S. Willroth G. deKant E. Lobeck H. Huhn D. Hermann R. Mutations in the ras protooncogenes are rare events in renal cell cancer Eur. J. Cancer 28 1992 333
82. Kozma L. Kiss I. Nagy A. Szakáll S. Ember I. Investigation of c-myc and K-ras amplification in renal clear cell adenocarcinoma Cancer Lett. 111 1997 127
83. Walther M.M. Kleiner D.E. Lubensky I.A. Pozzatti R. Nyguen T. Gnawa J.R. Hurley K. Venzon D. Linehan W.M. Stetter-Stevenson W.G. Progelatinase A mRNA expression in cell lines derived from tumors in patients with metastatic renal cell carcinoma correlates inversely with survival Urology 50 1997 295
84. Kovacs G. Papillary renal cell carcinoma. A morphologic and cytogenetic study of 11 cases Amer. J. Path. 134 1989 27
85. Dijkhuizen T. van den Berg E. van den Berg A. Störkel S. De Jong B. Seitz G. Henn W. Chromosomal findings and p53-mutation analysis in chromophilic renal-cell carcinomas Int. J. Cancer 68 1996 47
86. Mancilla-Jimenez R. Stanley R.J. Blath R.A. Papillary renal cell carcinoma: a clinical, radiologic, and pathologic study of 34 cases Cancer 38 1976 2469
87. Delahunt B. Eble J.N. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors Mod. Path. 10 1997 537
88. Kovacs G. Wilkens L. Papp T. de Riese W. Differentiation between papillary and nonpapillary renal cell carcinomas by DNA analysis J. Natl. Cancer Inst. 81 1989 527
89. Orain I. Buzelin F. Ferry N. [Tubulopapillary tumors of the kidney. Apropos of 20 new cases and a review of the literature] J. Urol. (Paris) 93 1987 1
90. Amin M.B. Corless C.L. Renshaw A.A. Tickoo S.K. Kubus J. Schultz D.S. Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases Amer. J. Surg. Path. 21 1997 621
91. Renshaw A.A. Zhang H. Corless C.L. Fletcher J.A. Pins M.R. Solid variants of papillary (chromophil) renal cell carcinoma: clinicopathologic and genetic features Amer. J. Surg. Path. 21 1997 1203
92. Ishikawa I. Kovacs G. High incidence of papillary renal cell tumours in patients on chronic haemodialysis Histopathology 22 1993 135
93. Hughson M.D. Schmidt L. Zbar B. Daugherty S. Meloni A.M. Silva F.G. Sandberg A.A. Renal cell carcinoma of end-stage renal disease: a histopathologic and molecular genetic study J. Amer. Soc. Nephr. 7 1996 2461
94. Kovacs G. The value of molecular genetic analysis in the diagnosis and prognosis of renal cell tumours World J. Urol. 12 1994 64
95. Robson C.J. Churchill B.M. Anderson W. The results of radical nephrectomy for renal cell carcinoma J. Urol. 101 1969 297
96. Guinan P.D. Vogelzang N.J. Fremgen A.M. Chmiel J.S. Sylvester J.L. Sener S.F. Imperato J.P. members of the Cancer Incidence and End Results Committee: Renal cell carcinoma: tumor size, stage and survival J. Urol. 153 part 2 1995 901
97. Schmidt L. Junker K. Weirich G. Glenn G. Choyke P. Lubensky I. Zhuang Z. Jeffers M. Vande Woude G. Neumann H. Walther M. Linehan W.M. Zbar B. Two North American families with hereditary papillary renal carcinoma and identical novel mutations in the MET protooncogene Cancer Res. 58 1998 1719
98. Lubensky I.A., Weirich G., Pack S., Histopathology and Molecular Genetics of Hereditary Papillary Renal Cell Carcinoma. Unpublished data, 1998.
99. Schmidt L. Duh F.M. Chen F. Kishida T. Glenn G. Choyke P. Scherer S.W. Zhuang Z. Lubensky I. Dean M. Allikmets R. Chidambaram A. Bergerheim U.R. Feltis J.T. Casadevall C. Zamarron A. Bernues M. Richard S. Lips C.J. Walther M.M. Tsui L.C. Geil L. Orcutt M.L. Stackhouse T. Zbar B. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas Natl. Genet. 16 1997 68
100. Bernués M. Casadevall C. Miró R. Caballín M.R. Villavicencio H. Salvador J. Zamarrón A. Egozcue J. Cytogenetic characterization of a familial papillary renal cell carcinoma Cancer Genet. Cytogenet. 84 1995 123
101. Zhuang Z. Park W.S. Pack S. Schmidt L. Vortmeyer A.O. Pak E. Pham T. Weil R.J. Candidus S. Lubensky I.A. Linehan W.M. Zbar B. Weirich G. Trisomy 7-harbouring nonrandom duplication of the mutant MET allele in hereditary papillary renal carcinomas Natl. Genet. 20 1998 66
102. Kovacs G. Fuzesi L. Emanual A. Kung H.F. Cytogenetics of papillary renal cell tumors Genes Chromosomes Cancer 3 1991 249
103. Schmidt L. Junker K. Nakaigawa N. Kinjerski T. Weirich G. Miller M. Lubensky I. Neumann H.P. Brauch H. Decker J. Vocke C. Brown J.A. Jenkins R. Richard S. Bergerheim U. Gerrard B. Dean M. Linehan W.M. Zbar B. Novel mutations of the MET proto-oncogene in papillary renal carcinomas Oncogene 18 1999 2343
104. Jeffers M. Schmidt L. Nakaigawa N. Webb C.P. Weirich G. Kishida T. Zbar B. Vande Woude G.F. Activating mutations for the met tyrosine kinase receptor in human cancer Proc. Natl. Acad. Sci. 94 1997 11445
105. Hughson M.D. Johnson L.D. Silva F.G. Kovacs G. Nonpapillary and papillary renal cell carcinoma: a cytogenetic and phenotypic study Mod. Path. 6 1993 449
106. Meloni A.M. Bridge J. Sandberg A.A. Reviews on chromosome studies in urological tumors. I. Renal tumors J. Urol. 148 1992 253
107. Hughson M.D. Meloni A.M. Silva F.G. Sandberg A.A. Renal cell carcinoma in an end-stage kidney of a patient with a functional transplant: cytogenetic and molecular genetic findings Cancer Genet. Cytogenet. 89 1996 65
108. Bentz M. Bergerheim U.S. Li C. Joos S. Werner C.A. Baudis M. Gnarra J. Merino M.J. Zbar B. Linehan W.M. Lichter P. Chromosome imbalances in papillary renal cell carcinoma and first cytogenetic data of familial cases analyzed by comparative genomic hybridization Cytogenet. Cell Genet. 75 1996 17
109. Contractor H. Zariwala M. Bugert P. Zeisler J. Kovacs G. Mutation of the p53 tumour suppressor gene occurs preferentially in the chromophobe type of renal cell tumour J. Path. 181 1997 136
110. Henn W. Zwergel T. Wullich B. Thönnes M. Zang K.D. Seitz G. Bilateral multicentric papillary renal tumors with heteroclonal origin based on tissue-specific karyotype instability Cancer 72 1993 1315
111. Kovacs G. Tory K. Kovacs A. Development of papillary renal cell tumours is associated with loss of Y-chromosome-specific DNA sequences J. Path. 173 1994 39
112. De Jong B. Molenaar I.M. Leeuw J.A. Idenberg V.J. Oosterhuis J.W. Cytogenetics of a renal adenocarcinoma in a 2-year-old child Cancer Genet. Cytogenet. 21 1986 165
113. Tonk V. Wilson K.S. Timmons C.F. Schneider N.R. Tomlinson G.E. Renal cell carcinoma with translocation (X;1). Further evidence for a cytogenetically defined subtype Cancer Genet. Cytogenet. 81 1995 72
114. Kardas I. Denis A. Babinska M. Gronwald J. Podolski J. Zajaczek S. Kram A. Lubinski J. Limon J. Translocation (X;1)(p11.2;q21) in a papillary renal cell carcinoma in a 14-year-old girl Cancer Genet. Cytogenet. 101 1998 159
115. Sidhar S.K. Clark J. Gill S. Hamoudi R. Crew A.J. Gwilliam R. Ross M. Linehan W.M. Birdsall S. Shipley J. Cooper C.S. The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene Hum. Mol. Genet. 5 1996 1333
116. Shipley J.M. Birdsall S. Clark J. Crew J. Gill S. Linehan M. Gnarra J. Fisher S. Craig I.W. Cooper C.S. Mapping the X chromosome breakpoint in two papillary renal cell carcinoma cell lines with a t(X;1)(p11.2;q21.2) and the first report of a female case Cytogenet. Cell Genet. 71 1995 280
117. Weterman M.A. Wilbrink M. Janssen I. Janssen H.A. van den Berg E. Fisher S.E. Craig I. Geurts van Kessel A. Molecular cloning of the papillary renal cell carcinoma-associated translocation (X;1)(p11;q21) breakpoint Cytogenet. Cell Genet. 75 1996 2
118. Weterman M.A. Wilbrink M. Geurts van Kessel A. Fusion of the transcription factor TFE3 gene to a novel gene, PRCC, in t(X;1)(p11;q21)-positive papillary renal cell carcinomas Proc. Natl. Acad. Sci. 93 1996 15294
119. Thoenes W. Störkel S. Rumpelt H.J. Human chromophobe cell renal carcinoma. Virchows Arch B Cell Path Incl. Mol. Path. 48 1985 207
120. Storkel S. Classification of renal cell carcinoma: correlation of morphology and cytogenetics N.J. Vogelzang P.T. Scardino W.U. Shipley D.S. Coffey Comprehensive Textbook of Genitourinary Oncology 1996 Williams & Wilkins Baltimore 179 186
121. Crotty T.B. Farrow G.M. Lieber M.M. Chromophobe cell renal carcinoma: clinicopathological features of 50 cases J. Urol. 154 1995 964
122. Billis A. Carvalho R.B. Magrini E. Mattos A.C. Negretti F. Niero V.R. Nogueira C.R. Oliveira M.C. Piovesan H. Ramos M.J. Rocha A.G. Souza C.A. Valença Júnior J.T. Chromophobe renal cell carcinoma: clinicopathological study of 7 cases Ultrastruct. Path. 22 1998 19
123. Cochand-Priollet B. Molinié V. Bougaran J. Bouvier R. Dauge-Geffroy M.C. Deslignières S. Fournet J.C. Gros P. Lesourd A. Saint-André J.P. Toublanc M. Vieillefond A. Wassef M. Fontaine A. Groleau L. Renal chromophobe cell carcinoma and oncocytoma. A comparative morphologic, histochemical, and immunohistochemical study of 124 cases Arch. Path. Lab. Med. 121 1997 1081
124. Thoenes W. Storkel S. Rumpelt H.J. Moll R. Baum H.P. Werner S. Chromophobe cell renal carcinoma and its variants-a report on 32 cases J. Path. 155 1988 277
125. Tickoo S.K. Amin M.B. Zarbo R.J. Colloidal iron staining in renal epithelial neoplasms, including chromophobe renal cell carcinoma: emphasis on technique and patterns of staining Amer. J. Surg. Path. 22 1998 419
126. Durham J.R. Keohane M. Amin M.B. Chromophobe renal cell carcinoma Adv. Anat. Path. 3 1996 336
127. Störkel S. Steart P.V. Drenckhahn D. Thoenes W. The human chromophobe cell renal carcinoma: its probable relation to intercalated cells of the collecting duct Virchows Arch. B Cell Path. Incl. Mol. Path. 56 1989 237
128. Ortmann M. Vierbuchen M. Fischer R. Sialylated glycoconjugates in chromophobe cell renal carcinoma compared with other renal cell tumors. Indication of its development from the collecting duct epithelium Virchows Arch. B Cell Path. Incl. Mol. Path. 61 1991 123
129. Thoenes W. Rumpelt H.J. Storkel S. Classification of renal cell carcinoma/tumors and their relationship to the nephron-collecting tubules system Klin. Wochenschr. 68 1990 1102
130. Kovacs G. Soudah B. Hoene E. Binucleated cells in a human renal cell carcinoma with 34 chromosomes Cancer Genet. Cytogenet. 31 1988 211
131. Kovacs A. Kovacs G. Low chromosome number in chromophobe renal cell carcinomas Genes Chromosomes Cancer 4 1992 267
132. Iqbal M.A. Akhtar M. Ali M.A. Cytogenetic findings in renal cell carcinoma Hum. Path. 27 1996 949
133. Speicher M.R. Schoell B. du Manoir S. Schrock E. Ried T. Cremer T. Storkel S. Kovacs A. Kovacs G. Specific loss of chromosomes 1, 2, 6, 10, 13, 17, and 21 in chromophobe renal cell carcinomas revealed by comparative genomic hybridization Amer. J. Path. 145 1994 356
134. Schwerdtle R.F. Störkel S. Neuhaus C. Brauch H. Weidt E. Brenner W. Hohenfellner R. Huber C. Decker H.J. Allelic losses at chromosomes 1p, 2p, 6p, 10p, 13q, 17p, and 21q significantly correlate with the chromophobe subtype of renal cell carcinoma Cancer Res. 56 1996 2927
135. Bugert P. Gaul C. Weber K. Herbers J. Akhtar M. Ljungberg B. Kovacs G. Specific genetic changes of diagnostic importance in chromophobe renal cell carcinomas Lab. Invest. 76 1997 203
136. Kovacs A. Storkel S. Thoenes W. Kovacs G. Mitochondrial and chromosomal DNA alterations in human chromophobe renal cell carcinomas J. Path. 167 1992 273
137. Fleming S. Lewi H.J. Collecting duct carcinoma of the kidney Histopathology 10 1986 1131
138. Rumpelt H.J. Störkel S. Moll R. Schärfe T. Thoenes W. Bellini duct carcinoma: further evidence for this rare variant of renal cell carcinoma Histopathology 18 1991 115
139. Kennedy S.M. Merino M.J. Linehan W.M. Roberts J.R. Robertson C.N. Neumann R.D. Collecting duct carcinoma of the kidney Hum. Path. 21 1990 449
140. Baer S.C. Ro J.Y. Ordonez N.G. Maiese R.L. Loose J.H. Grignon D.G. Ayala A.G. Sarcomatoid collecting duct carcinoma: a clinicopathologic and immunohistochemical study of five cases Hum. Path. 24 1993 1017
141. Dimopoulos M.A. Logothetis C.J. Markowitz A. Sella A. Amato R. Ro J. Collecting duct carcinoma of the kidney Brit. J. Urol. 71 1993 388
142. Fleming S. Symes C.E. The distribution of cytokeratin antigens in the kidney and in renal tumours Histopathology 11 1987 157
143. Cavazzana A.O. Prayer-Galetti T. Tirabosco R. Macciomei M.C. Stella M. Lania L. Cannada-Bartoli P. Spagnoli L.G. Passerini-Glazel G. Pagano F. Bellini duct carcinoma. A clinical and in vitro study Eur. Urol. 30 1996 340
144. Gregori-Romero M.A. Morell-Quadreny L. Llombart-Bosch A. Cytogenetic analysis of three primary Bellini duct carcinomas Genes Chromosomes Cancer 15 1996 170
145. Polascik T.J. Cairns P. Epstein J.I. Fuzesi L. Ro J.Y. Marshall F.F. Sidransky D. Schoenberg M. Distal nephron renal tumors: microsatellite allelotype Cancer Res. 56 1996 1892
146. Steiner G. Cairns P. Polascik T.J. Marshall F.F. Epstein J.I. Sidransky D. Schoenberg M. High-density mapping of chromosomal arm 1q in renal collecting duct carcinoma: region of minimal deletion at 1q32.1-32.2 Cancer Res. 56 1996 5044
147. Schoenberg M. Cairns P. Brooks J.D. Marshall F.F. Epstein J.I. Isaacs W.B. Sidransky D. Frequent loss of chromosome arms 8p and 13q in collecting duct carcinoma (CDC) of the kidney Genes Chromosomes Cancer 12 1995 76
148. Fogt F. Zhuang Z. Linehan W.M. Merino M.J. Collecting duct carcinomas of the kidney: a comparative loss of heterozygosity study with clear cell renal cell carcinoma Oncology Rep. 5 1998 923
149. Selli C. Amorosi A. Vona G. Sestini R. Travaglini F. Bartoletti R. Orlando C. Retrospective evaluation of c-erbB-2 oncogene amplification using competitive PCR in collecting duct carcinoma of the kidney J. Urol. 158 1997 245
150. Coombs L.M. Pigott D.A. Sweeney E. Proctor A.J. Eydmann M.E. Parkinson C. Knowles M.A. Amplification and over-expression of c-erbB-2 in transitional cell carcinoma of the urinary bladder Brit. J. Cancer 63 1991 601
151. Stumm G. Eberwein S. Rostock-Wolf S. Stein H. Pomer S. Schlegel J. Waldherr R. Concomitant overexpression of the EGFR and erbB-2 genes in renal cell carcinoma (RCC) is correlated with dedifferentiation and metastasis Int. J. Cancer 69 1996 17
152. Davis C.J. Jr. Mostofi F.K. Sesterhenn I.A. Renal medullary carcinoma. The seventh sickle cell nephropathy Amer. J. Surg. Path. 19 1995 1
153. Avery R.A. Harris J.E. Davis C.J. Jr. Borgaonkar D.S. Byrd J.C. Weiss R.B. Renal medullary carcinoma: clinical and therapeutic aspects of a newly described tumor Cancer 78 1996 128
154. Herring J.C. Schmetz M.A. Digan A.B. Young S.T. Kalloo N.B. Renal medullary carcinoma: a recently described highly aggressive renal tumor in young black patients J. Urol. 157 1997 2246
155. Friedrichs P. Lassen P. Canby E. Graham C. Renal medullary carcinoma and sickle cell trait J. Urol. 157 1997 1349
156. Davidson A.J. Choyke P.L. Hartman D.S. Davis C.J. Jr. Renal medullary carcinoma associated with sickle cell trait: radiologic findings Radiology 195 1995 83
157. Deisseroth A. Nienhuis A. Lawrence J. Giles R. Turner P. Ruddle F.H. Chromosomal localization of human beta globin gene on human chromosome 11 in somatic cell hybrids Proc. Natl. Acad. Sci. 75 1978 1456
158. Lieber M.M. Tomera K.M. Farrow G.M. Renal oncocytoma J. Urol. 125 1981 481
159. Fairchild T.N. Dail D.H. Brannen G.E. Renal oncocytoma-bilateral, multifocal Urology 22 1983 355
160. Zerban H. Nogueira E. Riedasch G. Bannasch P. Renal oncocytoma: origin from the collecting duct Virchows Arch. B Cell Path. Incl. Mol. Path. 52 1987 375
161. Amin M.B. Crotty T.B. Tickoo S.K. Farrow G.M. Renal oncocytoma: a reappraisal of morphologic features with clinicopathologic findings in 80 cases Amer. J. Surg. Path. 21 1997 1
162. Perez-Ordonez B. Hamed G. Campbell S. Erlandson R.A. Russo P. Gaudin P.B. Reuter V.E. Renal oncocytoma: a clinicopathologic study of 70 cases Amer. J. Surg. Path. 21 1997 871
163. Lieber M.M. Renal oncocytoma: prognosis and treatment Eur. Urol. 18 suppl. 1990 17
164. Erlandson R.A. Shek T.W. Reuter V.E. Diagnostic significance of mitochondria in four types of renal epithelial neoplasms: an ultrastructural study of 60 tumors Ultrastruct. Path. 21 1997 409
165. Merino M.J. Livolsi V.A. Oncocytomas of the kidney Cancer 50 1982 1852
166. Spring D.B. Ulirsch R.C. Starke W.R. Brown S. Jr. Renal oncocytoma followed for eighteen years without resection Urology 26 1985 389
167. Zhang G. Monda L. Wasserman N.F. Fraley E.E. Bilateral renal oncocytoma: report of 2 cases and literature review J. Urol. 133 1985 84
168. Vartanian O. Silfverswärd C. Preoperative diagnosis of renal oncocytoma and treatment possibilities Int. Urol. Nephrol. 18 1986 389
169. D'Addario P.F. Nyberg L.M. Renal oncocytoma: a benign tumor often misdiagnosed as malignant. Case reports and a diagnostic protocol Conn. Med. 52 1988 581
170. Kovacs G. Welter C. Wilkens L. Blin N. Deriese W. Renal oncocytoma. A phenotypic and genotypic entity of renal parenchymal tumors Am. J. Path. 134 1989 967
171. Tallini G. Ladanyi M. Rosai J. Jhanwar S.C. Analysis of nuclear and mitochondrial DNA alterations in thyroid and renal oncocytic tumors Cytogenet. Cell Genet. 66 1994 253
172. Brown J.A. Takahashi S. Alcaraz A. Borell T.J. Anderl K.L. Qian J. Persons D.L. Bostwick D.G. Lieber M.M. Jenkins R.B. Fluorescence in situ hybridization analysis of renal oncocytoma reveals frequent loss of chromosomes Y and 1 J. Urol. 156 1996 31
173. Herbers J. Schullerus D. Chudek J. Bugert P. Kanamaru H. Zeisler J. Ljungberg B. Akhtar M. Kovacs G. Lack of genetic changes at specific genomic sites separates renal oncocytomas from renal cell carcinomas J. Path. 184 1998 58
174. Psihramis K.E. Dal Cin P. Dretler S.P. Prout G.R. Jr. Sandberg A.A. Further evidence that renal oncocytoma has malignant potential J. Urol. 139 1988 585
175. Crotty T.B. Lawrence K.M. Moertel C.A. Bartelt D.H. Jr. Batts K.P. Dewald G.W. Farrow G.M. Jenkins R.B. Cytogenetic analysis of six renal oncocytomas and a chromophobe cell renal carcinoma. Evidence that -Y, -1 may be a characteristic anomaly in renal oncocytomas Cancer Genet. Cytogenet. 61 1992 61
176. Meloni A.M. Sandberg A.A. White R.D. -Y, -1 as recurrent anomaly in oncocytoma Cancer Genet. Cytogenet. 61 1992 108
177. van den Berg E. Dijkhuizen T. Störkel S. de la Rivière G.B. Dam A. Mensink H.J. Oosterhuis J.W. de Jong B. Chromosomal changes in renal oncocytomas. Evidence that t(5;11)(q35;q13) may characterize a second subgroup of oncocytomas Cancer Genet. Cytogenet. 79 1995 164
178. Thrash-Bingham C.A. Salazar H. Greenberg R.E. Tartof K.D. Loss of heterozygosity studies indicate that chromosome arm 1p harbors a tumor supressor gene for renal oncocytomas Genes Chromosomes Cancer 16 1996 64
179. Presti J.C. Jr. Rao P.H. Chen Q. Reuter V.E. Li F.P. Fair W.R. Jhanwar S.C. Histopathological, cytogenetic, and molecular characterization of renal cortical tumors Cancer Res. 51 1991 1544
180. Sinke R.J. Dijkhuizen T. Janssen B. Olde Weghuis D. Merkx G. van den Berg E. Schuuring E. Meloni A.M. de Jong B. Geurts van Kessel A. Fine mapping of the human renal oncocytoma-associated translocation (5;11)(q35;q13) breakpoint Cancer Genet. Cytogenet. 96 1997 95
181. Walter T.A. Pennington R.D. Decker H-J. Sandberg A.A. Translocation t(9;11)(p23;q12): a primary chromosomal change in renal oncocytoma J. Urol. 142 1989 117
182. Füzesi L. Gunawan B. Braun S. Boeckmann W. Renal oncocytoma with a translocation t(9;11)(p23;q13) J. Urol. 152 1994 471
183. Neuhaus C. Dijkhuizen T. van den Berg E. Störkel S. Stöckle M. Mensch B. Huber C. Decker H.J. Involvement of the chromosomal region 11q13 in renal oncocytoma: case report and literature review Cancer Genet. Cytogenet. 94 1997 95
184. Kovacs G. Szücs S. Eichner W. Maschek H.J. Wahnschaffe U. De Riese W. Renal oncocytoma. A cytogenetic and morphologic study Cancer 59 1987 2071
185. Dal Cin P. Van Poppel H. Sciot R. De Vos R. Van Damme B. Baert L. van den Berghe H. The t(1;12)(p36;q13) in a renal oncocytoma Genes Chromosomes Cancer 17 1996 136
186. Psihramis K.E. Althausen A.F. Yoshida M.A. Prout G.R. Jr. Sandberg A.A. Chromosome anomalies suggestive of malignant transformation in bilateral renal oncocytoma J. Urol. 136 1986 892
187. Gregori-Romero M.A. Morell-Quadreny L. Llombart-Bosch A. A singular case of near-haploid stemline karyotype in a renal oncocytoma Cancer Genet. Cytogenet. 92 1996 28
188. Schwerdtle R.F. Winterpacht A. Störkel S. Brenner W. Hohenfellner R. Zabel B. Huber C. Decker H.J. Loss of heterozygosity studies and deletion mapping identify two putative chromosome 14q tumor suppressor loci in renal oncocytomas Cancer Res. 57 1997 5009
189. Holzmann K. Blin N. Welter C. Zang K.D. Seitz G. Henn W. Telomeric associations and loss of telomeric DNA repeats in renal tumors Genes Chromosomes Cancer 6 1993 178
190. Welter C. Kovacs G. Seitz G. Blin N. Alteration of mitochondrial DNA in human oncocytomas Genes Chromosomes Cancer 1 1989 79
191. Grignon D.J. Eble J.N. Papillary and metanephric adenomas of the kidney Sem. Diagn. Path. 15 1998 41
192. Brown J.A. Anderl K.L. Borell T.J. Qian J. Bostwick D.G. Jenkins R.B. Simultaneous chromosome 7 and 17 gain and sex chromosome loss provide evidence that renal metanephric adenoma is related to papillary renal cell carcinoma J. Urol. 158 1997 370
193. Brisigotti M. Cozzutto C. Fabbretti G. Sergi C. Callea F. Metanephric adenoma Histol. Histopathol. 7 1992 689
194. Jones E.C. Pins M. Dickersin G.R. Young R.H. Metanephric adenoma of the kidney. A clinicopathological, immunohistochemical, flow cytometric, cytogenetic, and electron microscopic study of seven cases Amer. J. Surg. Path. 19 1995 615
195. Gatalica Z. Grujic S. Kovatich A. Petersen R.O. Metanephric adenoma: histology, immunophenotype, cytogenetics, ultrastructure Mod. Path. 9 1996 329
196. Renshaw A.A. Maurici D. Fletcher J.A. Cytologic and fluorescence in situ hybridization (FISH) examination of metanephric adenoma Diagn. Cytopath. 16 1997 107
197. Brown J.A. Sebo T.J. Segura J.W. Metaphase analysis of metanephric adenoma reveals chromosome Y loss with chromosome 7 and 17 gain Urology 48 1996 473
198. Akhtar M. Kardar H. Linjawi T. McClintock J. Ali M.A. Chromophobe cell carcinoma of the kidney. A clinicopathologic study of 21 cases Amer. J. Surg. Path. 19 1995 1245
199. Lewi H.J. Alexander C.A. Fleming S. Renal oncocytoma Brit. J. Urol. 58 1986 12